.

Cytokinetics reported $85K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Amgen AMGN:US $ 31343M 96M
Arca Biopharma ABIO:US $ 0.01M 0M
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Brainstorm Cell Therapeutics BCLI:US $ 0.01M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Capricor Therapeutics CAPR:US $ 0.02M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Eisai 4523:JP Y 44986M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Exelixis EXEL:US $ 0.32M 0M
Genocea Biosciences GNCA:US $ 0.06M 0M
Geron GERN:US $ 0.38M 0.05M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Novartis NOVN:VX SF 890M 11M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M